[1]罗丹,陈姝宁,孔为民*.宫颈癌治疗对患者排便功能影响的研究[J].中国计划生育和妇产科,2020,(5):81-84.
 LUO Dan,CHEN Shuning,KONG Weimin*.Study on the effect of cervical cancer treatment on patients'defecationfunction[J].Chinese Journal of Family Planning & Gynecotokology,2020,(5):81-84.
点击复制

宫颈癌治疗对患者排便功能影响的研究
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年5期
页码:
81-84
栏目:
论著与临床
出版日期:
2020-05-25

文章信息/Info

Title:
Study on the effect of cervical cancer treatment on patients'defecation function
作者:
罗丹陈姝宁孔为民*
首都医科大学附属北京妇产医院妇瘤科
Author(s):
LUO Dan CHEN Shuning KONG Weimin*
Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100006,P.R.China
关键词:
宫颈癌治疗便秘放射性直肠炎
Keywords:
cervical cancer treatmentconstipation radiation proctitis
分类号:
R 7373
摘要:
目的了解宫颈癌患者治疗后排便功能异常的发生情况及治疗方式对宫颈癌患者治疗后排便功能的影响。方法选取2018年12月至2019年4月就诊于首都医科大学附属北京妇产医院妇科肿瘤门诊、宫颈癌治疗后随访时间≥3个月的患者,进行关于排便功能的问卷调查。根据不同治疗方法分为3组:手术治疗组(A组,47例)、放(化)疗组(B组,144例)、手术加放(化)疗组(C组,40例)。比较3组患者排便功能异常情况。结果231例宫颈癌治疗后随访患者中有118例(5108 %)发生排便异常,其中17例发生便秘(736 %);104例患者发生放射性直肠炎(5652 %)。A组便秘的发生率高于B组(1702 % vs 347 %, P<005),A组与C组便秘发生率比较,差异无统计学意义(P>005);B组放射性直肠炎发生率显著高于C组(6389 % vs 3000 %,P<005)。结论宫颈癌患者治疗后排便功能异常较为常见,应引起临床医师重视。与单纯手术相比,术后辅助放(化)疗不增加便秘的发生率。与单纯放疗患者相比,手术后放(化)疗患者放射性直肠炎发生率更低。
Abstract:
ObjectiveTo investigate abnormal defecation function of the patients with cervical cancer after treatment,and to discuss the effect of different therapies on defecation functions after treatment. MethodsSelected patients who were treated in the Gynecological Oncology Clinic of the Beijing Obstetrics and Gynecology Hospital affiliated to Capital Medical University from December 2018 to April 2019, and were followed up for more than 3 months after cervical cancer treatment. Data were collected through questionnaire of defecation function. According to different treatments,they were divided into three groups: surgical treatment group (group A,47 cases), radiotherapy (or chemoradiotherapy) group (group B,144 cases), Surgical + radiotherapy (or chemoradiotherapy) group (group C,40 cases). Compared the abnormal defecation function among the three groups.ResultsOf the 231 patients with cervical cancer treated and followed up,118 cases (5108 %) had abnormal defecation function, of which 17 had constipation (736 %); 104 had radiation proctitis (5652 %). The incidence of constipation in group A was higher than that in group B (1702 % vs 347 %, P<005). There was no significant difference in the incidence of constipation between group A and group C (P>005); the incidence of radiation proctitis in group B was significantly higher than that in group C (6389 % vs 3000 %, P<005). ConclusionAbnormal defecation is prevalence in women treated for cervical cancer. This fact should arouse the attention of clinicians.Postoperative adjuvant radiotherapy does not increase the incidence of constipation. The incidence of radiation proctitis was lower in patients treated with surgical and radiotherapy than in radiotherapy.

参考文献/References:

[1]Torre LA, Islami F, Siegel RL, et al. Global cancer in women: Burden and trends [J]. Cancer Epidemiol Biomarkers Prev, 2017, 26(4):444457. [2]Dahiya N, Acharya AS, Bachani D, et al. Quality of life of patients with advanced cervical cancer before and after chemoradiotherapy[J]. Asian Pac J Cancer Prev, 2016, 17(7):30953099. [3]Sabulei C, Maree JE. An exploration into the quality of life of women treated for cervical cancer [J].Curationis, 2019, 42(1):e 1e 9. [4]中国医师协会肛肠医师分会.便秘外科诊治指南(2017) [J].中华胃肠外科杂志,2017, 20(3):241243. [5]中国医师协会外科医师分会,中华医学会外科学分会结直肠外科学组.中国放射性直肠炎诊治专家共识(2018 版) [J].中华胃肠外科杂志, 2018, 21(12):13211336. [6]Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin, 2018, 68(6):394424. [7]Plotti F, Terranova C, Capriglione S, et al. Assessment of quality of life and urinary and sexual function after radical hysterectomy in longterm cervical cancer survivors [J].Int J Gynecol Cancer, 2018, 28(4):818823. [8]Bretschneider CE, Doll KM, Bensen JT, et al. Prevalence of pelvic floor disorders in women with suspected gynecological malignancy: a surveybased study [J].IntUrogynecol J, 2016, 27(9):14091414. [9]Isohashi F, Mabuchi S, Yoshioka Y, et al. Postoperative whole pelvic intensity modulated radiation therapy in surgically treated cervical cancer patients with adverse risk factors [J].Int J Radiat Oncol Biol Phys,2016, 96(2S): E 312. [10]刘瑶,孔为民,宋丹,等.同步放化疗治疗Ib2和IIa2期宫颈癌疗效及预后相关因素分析 [J].现代妇产科进展,2017,26(8):574577. [11]张同庆,孔为民.宫颈癌放射性直肠炎的诊治进展 [J].肿瘤学杂志, 2014, 20(12):972976. [12]葛阳清,侯金凤,曾敏,等.腹腔镜改良保留盆腔自主神经宫颈癌根治术治疗早期宫颈癌的疗效分析 [J].中国医师杂志,2017,19(8):11961199. [13]王志红,黄冬梅,邓克红,等.腹腔镜下保留盆腔自主神经的广泛性子宫切除术对Ib1期育龄期宫颈癌患者术后肛门直肠功能和性功能的影响 [J].肿瘤基础与临床,2017, 30(6):500503.

相似文献/References:

[1]冯学宇,乔银川,王好宁,等.823例宫颈癌机会性筛查结果分析[J].中国计划生育和妇产科,2010,(01):0.
 FENG Xue-yu,QIAO Yin-chuan,WANG Hao-ning ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(5):0.
[2]刘佳汭.保留盆腔自主神经的宫颈癌根治性手术[J].中国计划生育和妇产科,2010,(02):0.
[3]刘红,樊英,张国楠,等.子宫内膜浆液性腺癌的临床研究进展[J].中国计划生育和妇产科,2010,(03):0.
[4]李桂兰.青春期子宫内膜异位症的诊治进展[J].中国计划生育和妇产科,2010,(03):0.
[5]甘玉杰,熊小英,蔡春芳,等.血清SCCA、CA125、CA19-9与高危型人乳头状瘤病毒在宫颈癌及癌前病变中的表达及意义[J].中国计划生育和妇产科,2010,(04):0.
 GAN Yu-jie,XIONG Xiao-ying,CAI Chun-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(5):0.
[6]刘彩艳.宫角妊娠34例诊治分析[J].中国计划生育和妇产科,2010,(04):0.
[7]何博.妊娠合并先天性心脏病的诊治研究进展[J].中国计划生育和妇产科,2010,(04):0.
[8]肖春燕,陈桂珍,铁木帅龙,等.325例宫颈病变阴道镜检查结果分析[J].中国计划生育和妇产科,2010,(05):0.
 XIAO Chun-yan,CHEN Gui-zhen,TIEMU-Shuailong.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(5):0.
[9]卢庆.妊娠期急性脂肪肝研究进展[J].中国计划生育和妇产科,2010,(05):0.
[10]张兰,张波,邱艳,等.甲氨蝶呤联合米非司酮治疗未破裂型输卵管妊娠的价值[J].中国计划生育和妇产科,2010,(06):0.
 ZHANG Lan,ZHANG Bo,QIU Yan..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(5):0.
[11]黄晨玲子,罗新.清除下生殖道高危型人乳头瘤病毒感染的可行性与必要性[J].中国计划生育和妇产科,2016,(09):0.
 Huang Chen-lingzi,Luo Xin,[J].Chinese Journal of Family Planning & Gynecotokology,2016,(5):0.
[12]谢玲玲,林仲秋*.妊娠期宫颈癌处理进展及临床争议[J].中国计划生育和妇产科,2019,(2):10.

更新日期/Last Update: 2020-05-25